Niki BioSolutions, Inc. Common Stock (NIKI) Stock Price
NIKIStock
$2.03
Market Cap$6.33M
P/E—
PEG Ratio—
Div yield—
Beta0.09
NIKI Share Price Chart
Favorite Metrics
Price vs S&P 500 (4W)-57.83%
VGM Score3.13
NIKI Analyst Recommendations
Jun 2023
Jul 2023
Aug 2023
Sep 2023
4.13
4.13
4.13
4.13
Industry Peers — Measuring & Controlling Devices(11)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
NIKINiki BioSolutions, Inc. Common Stock | — | — | F | 5.3x | — | 7.1% | -1298.4% | $2.03 |
| TMOThermo Fisher Scientific, Inc. | D | C | A | 5.5x | 6.7% | 40.9% | 17.6% | $690.00 |
| ROKRockwell Automation, Inc. | D | C | B | 5.3x | 5.7% | 54.5% | 14.7% | $426.23 |
| TRMBTrimble Inc. Common Stock | C | C | B | 3.6x | -0.4% | 70.5% | 3.7% | $59.46 |
| ONTOOnto Innovation Inc. | D | B | C | 9.7x | 12.6% | 55.1% | 12.0% | $220.70 |
| MIRMirion Technologies, Inc. | C | B | C | 3.7x | 8.6% | 48.0% | 5.3% | $15.15 |
| QSIQuantum-Si Incorporated Class A Common Stock | D | F | C | 152.7x | — | 35.0% | -6887.8% | $1.12 |
| OWLTOwlet, Inc. | B | B | D | 1.0x | 7.0% | 54.8% | -8.4% | $4.11 |
| GEOSGeospace Technologies Corporation Common Stock | B | F | D | 0.6x | 4.8% | 8.0% | -44.6% | $4.41 |
| BCHTBirchtech Corp. | B | B | D | 1.6x | 16.6% | 39.7% | -23.6% | $1.18 |
| APMAptorum Group Limited Class A Ordinary Shares | C | — | D | 4.7x | — | 7.1% | -1298.4% | $4.82 |
About Niki BioSolutions, Inc. Common Stock
Niki BioSolutions Inc, formerly Aptorum Group Ltd is a clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. Its project pipeline includes SACT-1, a repurposed drug for the treatment of neuroblastoma, and ALS-4, a small molecule for the treatment of bacterial infections caused by Staphylococcus aureus, including but not limited to Methicillin-resistant Staphylococcus aureus (MRSA).